Press Resease

COVID-19 Drug Delivery Devices Market by Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), by Route of Administration (Parenteral, Nasal, and Dermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Published Date: 06-Aug-2020 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5367 Status : Published

Global demand for COVID-19 Drug Delivery Devices Market was valued at approximately USD 2,232.7 Million in 2019, and is expected to generate revenue of around USD 3,901.5 Million by end of 2026, growing at a CAGR of around 8.3% between 2020 and 2026

Description

The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-19 drug delivery devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the COVID-19 drug delivery devices market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the COVID-19 drug delivery devices market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, route of administration, distribution channels, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

COVID-19 Drug Delivery Devices Market

The report provides company market share analysis in order to give a broader overview of the key players in the COVID-19 drug delivery devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the COVID-19 drug delivery devices market on global and regional basis.

The study provides a decisive view on the COVID-19 drug delivery devices market by segmenting the market based on the product, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2026. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global COVID-19 drug delivery devices market. Some of the key players of COVID-19 drug delivery devices market are Bharat Biotech, Serum Institute of India, AstraZeneca, Johnson & Johnson, Pfizer, PharmaJet, Moderna, Novawax, Inc., and GlaxoSmithKline Plc among others.

This report segments the global COVID-19 drug delivery devices market as follows:

Global COVID-19 Drug Delivery Devices Market: By Product

  • Prefilled Syringes
  • Needle-Free Injectors
  • Inhalers
  • Patches
  • Others

Global COVID-19 Drug Delivery Devices Market: By Route of Administration    

  • Parenteral
  • Nasal
  • Dermal

Global COVID-19 Drug Delivery Devices Market: By Distribution Channel         

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global COVID-19 Drug Delivery Devices Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. COVID-19 Drug Delivery Devices Market, 2016 – 2026 (USD Million)
    • 2.2. COVID-19 Drug Delivery Devices Market: Snapshot
  • Chapter 3. COVID-19 Drug Delivery Devices Market – Industry Analysis
    • 3.1. COVID-19 Drug Delivery Devices Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Development of novel non-invasive drug delivery technulogies
      • 3.2.2. Growth in government funding to support vaccine production
      • 3.2.3. Increasing cullaborations among universities and market players
    • 3.3. Restraints
      • 3.3.1. Limited vaccine production facilities and lack of data supporting efficacy
      • 3.3.2. High research and development costs
    • 3.4. Opportunities
      • 3.4.1. Technological advancements
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Product
      • 3.6.2. Market attractiveness analysis by Route of Administration
      • 3.6.3. Market attractiveness analysis by Distribution Channel
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. COVID-19 Drug Delivery Devices Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global COVID-19 Drug Delivery Devices Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global COVID-19 Drug Delivery Devices Market – Product Analysis
    • 5.1. Global COVID-19 Drug Delivery Devices Market overview: by Product
      • 5.1.1. Global COVID-19 Drug Delivery Devices Market share, by Product, 2019 and 2026
    • 5.2. Prefilled Syringes
      • 5.2.1. Global COVID-19 Drug Delivery Devices Market by Prefilled Syringes, 2016 – 2026 (USD Million)
    • 5.3. Needle-Free Injectors
      • 5.3.1. Global COVID-19 Drug Delivery Devices Market by Needle-Free Injectors, 2016 – 2026 (USD Million)
    • 5.4. Inhalers
      • 5.4.1. Global COVID-19 Drug Delivery Devices Market by Inhalers, 2016 – 2026 (USD Million)
    • 5.5. Patches
      • 5.5.1. Global COVID-19 Drug Delivery Devices Market by Patches, 2016 – 2026 (USD Million)
    • 5.6. Others
      • 5.6.1. Global COVID-19 Drug Delivery Devices Market by Others, 2016 – 2026 (USD Million)
  • Chapter 6. Global COVID-19 Drug Delivery Devices Market – Route of Administration Analysis
    • 6.1. Global COVID-19 Drug Delivery Devices Market overview: by Route of Administration
      • 6.1.1. Global COVID-19 Drug Delivery Devices Market share, by Route of Administration, 2019 and 2026
    • 6.2. Parenteral
      • 6.2.1. Global COVID-19 Drug Delivery Devices Market by Parenteral, 2016 – 2026 (USD Million)
    • 6.3. Nasal
      • 6.3.1. Global COVID-19 Drug Delivery Devices Market by Nasal, 2016 – 2026 (USD Million)
    • 6.4. Dermal
      • 6.4.1. Global COVID-19 Drug Delivery Devices Market by Dermal, 2016 – 2026 (USD Million)
  • Chapter 7. Global COVID-19 Drug Delivery Devices Market – Distribution Channel Analysis
    • 7.1. Global COVID-19 Drug Delivery Devices Market overview: by Distribution Channel
      • 7.1.1. Global COVID-19 Drug Delivery Devices Market share, by Distribution Channel, 2019 and 2026
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global COVID-19 Drug Delivery Devices Market by Hospital Pharmacies, 2016 – 2026 (USD Million)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global COVID-19 Drug Delivery Devices Market by Retail Pharmacies, 2016 – 2026 (USD Million)
    • 7.4. Online Pharmacies
      • 7.4.1. Global COVID-19 Drug Delivery Devices Market by Online Pharmacies, 2016 – 2026 (USD Million)
  • Chapter 8. Global COVID-19 Drug Delivery Devices Market - Regional Analysis
    • 8.1. Global COVID-19 Drug Delivery Devices Market overview: by Region
      • 8.1.1. Global COVID-19 Drug Delivery Devices Market share, by Region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America COVID-19 Drug Delivery Devices Market, 2016 – 2026 (USD Million)
      • 8.2.2. North America COVID-19 Drug Delivery Devices Market revenue, by Country, 2016 – 2026 (USD Million)
      • 8.2.3. North America COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
      • 8.2.4. North America COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
      • 8.2.5. North America COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.2.6. U.S.
        • 8.2.6.1. U.S. COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.2.6.2. U.S. COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.2.6.3. U.S. COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.2.7. Rest of North America
        • 8.2.7.1. Rest of North America COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.2.7.2. Rest of North America COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.2.7.3. Rest of North America COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe COVID-19 Drug Delivery Devices Market, 2016 – 2026 (USD Million)
      • 8.3.2. Europe COVID-19 Drug Delivery Devices Market revenue, by Country, 2016 – 2026 (USD Million)
      • 8.3.3. Europe COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
      • 8.3.4. Europe COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
      • 8.3.5. Europe COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.6. U.K.
        • 8.3.6.1. U.K. COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.3.6.2. U.K. COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.3.6.3. U.K. COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.7. France
        • 8.3.7.1. France COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.3.7.2. France COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.3.7.3. France COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.8. Germany
        • 8.3.8.1. Germany COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.3.8.2. Germany COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.3.8.3. Germany COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.3.9.2. Rest of Europe COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.3.9.3. Rest of Europe COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific COVID-19 Drug Delivery Devices Market, 2016 – 2026 (USD Million)
      • 8.4.2. Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Country, 2016 – 2026 (USD Million)
      • 8.4.3. Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
      • 8.4.4. Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
      • 8.4.5. Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.6. China
        • 8.4.6.1. China COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.4.6.2. China COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.4.6.3. China COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.7. Japan
        • 8.4.7.1. Japan COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.4.7.2. Japan COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.4.7.3. Japan COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.8. India
        • 8.4.8.1. India COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.4.8.2. India COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.4.8.3. India COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.4.9. Rest of Asia Pacific
        • 8.4.9.1. Rest of Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.4.9.2. Rest of Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.4.9.3. Rest of Asia Pacific COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America COVID-19 Drug Delivery Devices Market, 2016 – 2026 (USD Million)
      • 8.5.2. Latin America COVID-19 Drug Delivery Devices Market revenue, by Country, 2016 – 2026 (USD Million)
      • 8.5.3. Latin America COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
      • 8.5.4. Latin America COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
      • 8.5.5. Latin America COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.5.6. Brazil
        • 8.5.6.1. Brazil COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.5.6.2. Brazil COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.5.6.3. Brazil COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.5.7.2. Rest of Latin America COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.5.7.3. Rest of Latin America COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa COVID-19 Drug Delivery Devices Market, 2016 – 2026 (USD Million)
      • 8.6.2. The Middle East and Africa COVID-19 Drug Delivery Devices Market revenue, by Country, 2016 – 2026 (USD Million)
      • 8.6.3. The Middle East and Africa COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
      • 8.6.4. The Middle East and Africa COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
      • 8.6.5. The Middle East and Africa COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.6.6. GCC Countries
        • 8.6.6.1. GCC Countries COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.6.6.2. GCC Countries COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.6.6.3. GCC Countries COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 8.6.7. Rest of Middle East & Africa
        • 8.6.7.1. Rest of Middle East & Africa COVID-19 Drug Delivery Devices Market revenue, by Product, 2016 – 2026 (USD Million)
        • 8.6.7.2. Rest of Middle East & Africa COVID-19 Drug Delivery Devices Market revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 8.6.7.3. Rest of Middle East & Africa COVID-19 Drug Delivery Devices Market revenue, by Distribution Channel, 2016 – 2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Bharat Biotech
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Serum Institute of India
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. AstraZeneca
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Johnson & Johnson
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Pfizer
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. PharmaJet
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Moderna
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Novawax, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. GlaxoSmithKline Plc
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development

Methodology


Frequently Asked Questions

According to the report, global demand for COVID-19 drug delivery devices market was valued at approximately USD 2,232.7 Million in 2019, and is expected to generate revenue of around USD 3,901.5 Million by end of 2026, growing at a CAGR of around 8.3% between 2020 and 2026.

Over the projected era, Asia Pacific is expected to experience a substantial CAGR as the region consists of emerging economies. Large population base, increased funding for research and exponential recorded cases of COVID-19 are expected to boost regional market growth.

The report includes detailed profiles of some of the players like Bharat Biotech, Serum Institute of India, AstraZeneca, Johnson & Johnson, Pfizer, PharmaJet, Moderna, Novawax, Inc., and GlaxoSmithKline Plc among others.

The Prefilled Syringe Segment is expected to account for the largest revenue share in the forecast period as the government organizations are making several efforts to increase prefilled syringe output.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social